Introduction
Twenty four hour (circadian) patterns are present in numerous physiological processes. Circadian variation with a morning peak has been found in heart rate, blood pressure, 1,2 and levels of multiple hormones such as renin, aldosterone, and cortisol. 3, 4 It is becoming increasingly clear that adverse events follow circadian patterns as well. Circadian variation with a peak in the morning has been observed in stroke, 5 unstable angina pectoris, 6 acute myocardial infarction, 7, 8 and sudden cardiac death. 7, 9 In addition, weekly patterns with a peak on Monday and seasonal patterns with a peak in the winter have been reported in acute myocardial infarction, [10] [11] [12] and sudden cardiac death. 13, 14 The majority
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Part 1 -Symptom onset of these temporal patterns seem to be attributable to triggering factors, such as hemodynamic, and hemostatic changes, physical exertion, and mental stress. [15] [16] [17] [18] In theory, it is likely that coronary stent thrombosis also follows a circadian pattern, due to an increased tendency towards thrombosis in the morning hours. [18] [19] [20] However, this hypothesis has only been confirmed by 1 report with a sample size of 21 patients. 21 Furthermore, the role of triggering factors in stent thrombosis onset has been suggested in a case report. 22 More insight in patterns of onset of stent thrombosis and potential triggers may help to prevent stent thrombosis by optimizing medical treatment during high risk intervals throughout the day, week, and year. To address the hypothesis that stent thrombosis follows a circadian pattern, we performed an analysis of the Mayo Clinic Percutaneous Coronary Intervention (PCI) Registry. Secondarily, we assessed weekly and seasonal patterns and characterized potential triggering events preceding stent thrombosis onset.
Methods

Study design
After obtaining institutional review board approval, a retrospective analysis was performed, using the Mayo Clinic PCI Registry. This database includes baseline, procedural, angiographic, and outcome data on all patients undergoing PCI at the Mayo Clinic, Rochester, Minnesota. For this registry, data is prospectively collected by experienced interventional cardiology data technicians. The database supervisor performs routine audits of 10% of the records for quality control purposes. We identified patients admitted to our center who had undergone a repeated PCI procedure in a coronary artery segment where a stent had been previously placed and who had experienced sudden onset or worsening of anginal symptoms within a week of this repeated PCI procedure. The later criterion was determined by medical record review. We excluded patients with unknown symptom onset date and time and patients who had previously declined to have their medical records reviewed for research, as is required by Minnesota state law. We did not study patients with sudden death, since angiographic evidence of stent thrombosis could not be obtained in these patients. Subsequently, angiograms of eligible study subjects were reviewed for angiographic evidence of stent thrombosis by experienced interventional cardiology trainees blinded to the primary outcome of this study. Thus, the subjects we identified by means of this method have definite stent thrombosis according to the Academic Research Consortium (ARC) definition: "an acute coronary syndrome with angiographic or autopsy evidence of thrombus or occlusion". 23 In addition, medical records were reviewed for level of physical activity prior to symptom onset, and other events that had potentially triggered stent thrombosis were identified.
Definitions
In accordance with the ARC definition, stent thrombosis was subdivided into early stent thrombosis (0 to 30 days), late stent thrombosis (31 to 360 days), and very late stent thrombosis (>360 days). 23 Multivessel disease was defined as the number of vessels wherein the first had at least 70% stenosis and subsequent vessels at least 50% stenosis. For the index procedure (initial stent placement), lesion dissection was defined as the presence of an intimal tear during the procedure, regardless of its persistence after completion of the procedure, and stent size was defined as the smallest diameter of any stent placed in the coronary artery segment where stent thrombosis would later occur. Finally, arterial calcification and lesion calcification were defined as any visible calcium during coronary angiography. The level of physical activity prior to stent thrombosis symptom onset was graded using metabolic equivalents. One metabolic equivalent (MET) was defined as the energy spent per minute by a subject sitting quietly and is equivalent to 3.5 ml of oxygen uptake per kilogram of body weight per minute by a 70-kg adult. 15 This method has previously been used in studies assessing physical activity as a potential trigger of myocardial infarction. 15, 17 We defined the categories sleeping (1 MET), lying or sitting (1-2 METS), light to moderate exertion (3-5 METS), and heavy exertion (≥6 METS). Furthermore, we reviewed medical records for other potential triggers of stent thrombosis. This included documented medication noncompliance and patients who were initially admitted to our center for other medical conditions, but developed stent thrombosis during their hospitalization. Patients who were admitted for stent thrombosis, but were found to have other important medical conditions at admission (e.g. infection) were also considered to have a potential triggering factor for stent thrombosis.
Statistical analysis
Continuous variables are summarized as mean ± standard deviation, unless otherwise specified. Discrete variables are presented as fractions and percentages. Group differences for categorical variables were tested using Pearson's chi-squared test. The distribution of time of symptom onset over the 24-hour clock, week, and year were tested against the null hypothesis Part 1 -Symptom onset Values are mean ± standard deviation or n/N (%) All procedural and stent data relates to the coronary artery segment where stent thrombosis would later occur, except 'total number of stents', which relates to the index procedure as a whole. * Total % is >100%, because 3 patients had stent thrombosis in 2 vessels.
CHF, congestive heart failure; CAD, coronary artery disease; PTCA, percutaneous transluminal coronary angioplasty; TIMI, thrombolysis in myocardial infarction.
of a uniform likelihood using the Rayleigh test.
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For weekly and seasonal patterns, hour of week and day of year were used, respectively. To help identify the average temporal trends, sinusoidal functions were used to model stent thrombosis as functions of the time of symptom onset over the day, week, and year. The 4 degrees of freedom sinusoid consisted of one-period cosine, one-period sine, two-period cosine, and two-period sine variables. A two-tailed P value <0.05 was considered significant. All analyses were conducted with SAS 9.1.3 and JMP 8.0 (SAS Institute, Cary, North Carolina).
Results
Patient population
A total number of 1631 patients with a repeat intervention in a previously stented coronary artery segment were identified. In 252 patients, the onset of ischemic symptoms was within one week of intervention and symptom onset date and time could be obtained from the medical record. After angiographic review, a total number of 124 patients with definite stent thrombosis were identified. The other patients were found to have restenosis rather than stent thrombosis. Index procedures were performed between The spokes are drawn from the center of the circle to the number of stent thrombosis events that occurred that hour of the day; the spoke angles represent the time of day (rounded to the nearest hour). The scale is presented by concentric circles; the center of the circles represents zero frequency, the outer circle represents 12 stent thrombosis events. The dashed line is a sinusoidal smoothing function indicating the average circadian trends. The plot indicates that there was a low incidence of stent thrombosis around 19:00-24:00 and a peak incidence around 07:00. The association between onset of stent thrombosis and time of day was significant (P=0.006).
Part 1 -Symptom onset Table 1 . Unless otherwise specified, the procedural data had an ongoing malignancy or a history of malignancy in the past 5 years. Furthermore, after the index procedure, dissection of the coronary artery segment where stent thrombosis would later occur was present in 16% of patients.
Temporal variation
Stent thrombosis occurred after a median of 97 days of initial stent placement, with an interquartile range (IQR) of 4-862 days. The patient sample included 49 patients with early stent thrombosis (median 3 days after index procedure; IQR 1-5 days), 30 patients with late stent thrombosis (median 116 days; IQR 77-216 days), and 45 patients with very late stent thrombosis (median 38 months; IQR 26-63 months). The primary outcome, stent thrombosis as a function of 24 hour circadian time, is shown in Figure 1 . We found a significant association between the onset of stent thrombosis and time of day, with a low incidence around 20:00 and a peak around 07:00 (P=0.006). However, when patients were subdivided into early, late, and very late stent thrombosis, only the association between early stent thrombosis and time of day remained significant (P=0.030, P=0.537, and P=0.096, respectively; Figure 2 -4) . No significant association between stent thrombosis symptom onset and day of week was found (P=0.509). There was a significant association between stent thrombosis onset and day of year (P=0.034). Higher rates of stent thrombosis were found in the summer months, reaching peak incidences in July and August.
Figure 4. Circadian variation of very late stent thrombosis (n=45).
An explanation of the figure is provided in the legend of Figure 1 . No significant association between very late stent thrombosis and time of day was found (P=0. 096). There was, however, a trend towards a higher incidence of stent thrombosis between 06:00 and 12:00.
When looking at seasonal patterns, there were higher stent thrombosis rates in the summer months, with a peak occurrence between the end of July and the beginning of August (P=0.036; Figure 5 ).
relates to the coronary artery segment where stent thrombosis would later occur. Note that 33% of patients were diabetics, 19% of patients had peripheral vascular disease, and 15% of patients had
Procedure indication and medication use
Preprocedural medication use and indication for the index and stent thrombosis procedures are presented in Table 2 . Two thirds of the patients with stent thrombosis presented with myocardial infarction, most commonly ST-elevation myocardial infarction (STEMI). Overall, 96% of patients were on aspirin at the time of stent thrombosis. About 89% of patients with early stent thrombosis were on clopidogrel or ticlopidine, but less than half of the patients with late or very late stent thrombosis used these medications. When subdivided by type of stent, 86% of patients with a bare-metal stent and early stent thrombosis were using clopidogrel or ticlopidine before onset of stent thrombosis. This rate was 7 out of 20 (35%) for patients with a bare-metal stent and late stent thrombosis and 6 out of 25 (24%) for patients with a bare-metal stent and very late stent thrombosis. In patients with a drugeluting stent, 14 of 15 patients (93%) presenting with early stent thrombosis were using clopidogrel (none of the patients were on ticlopidine). This rate was only 6 out of 10 (60%) for patients Part 1 -Symptom onset Table 3 . In 5.6% of patients medication noncompliance was explicitly documented. Furthermore, 4% of patients were hospitalized for surgery or invasive diagnostics and developed stent thrombosis during this hospitalization. Finally, it is important to note that 4% of patients were found to have either pneumonia or a urinary tract infection at admission to our center. 19 demonstrated that tissue-type plasminogen activator (t-PA), the major component of the fibrinolytic system, was reduced in the morning, reaching lowest values at 06:00. At the same time, the activity of the fast-acting inhibitor of fibrinolysis, plasminogen activator inhibitor (PAI), was increased. Finally, antithrombotic medication such as aspirin, clopidogrel, and ticlopidine are likely to have nadir levels in the morning, just before waking up and taking a new dose. Our study confirms a previous report on circadian variation in stent thrombosis. To our knowledge, there has only been one prior study that assessed circadian variation of stent thrombosis in a group of 21 patients. 21 Tamura and coworkers found a higher morning incidence of subacute stent thrombosis in patients with a bare-metal stent. However, this study used 6-hour intervals and did not assess weekly and seasonal patterns due to a limited sample size. In addition to a circadian variation, we found a higher occurrence of stent thrombosis in the summer months. An intuitive explanation may be that patients were more active in the warm months of the year compared to the cold months. However, most reports assessing seasonal patterns in acute myocardial infarction find higher incidences in the winter months. 10, 11 Still, even passive heating in the summer can cause sympathetic nervous system activation and increased heart rate and thus may explain higher stent thrombosis rates in the summer.
Discussion
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We did not find a significant association between onset of stent thrombosis and day of the week. In other cardiovascular conditions, such as acute myocardial infarction, higher occurrences have been found on Monday. 11, 12 It is likely that mental stress accounts for this pattern, since it is less pronounced in the non-working population. The absence of this pattern in stent thrombosis may suggest a more limited role of mental stress as a triggering factor for stent thrombosis. When looking at the baseline characteristics of our patients, high rates of diabetes, peripheral vascular disease, malignancy, and dissection were found. These conditions have shown to be independent risk factors for stent thrombosis in a study by van Werkum and colleagues. 32 In addition to these data, we tried to establish physical activity level and other potential triggers for stent thrombosis onset. Although there is a great body of evidence with regard to the role of triggers in onset of acute myocardial infarction and sudden cardiac death, this is not the case for stent thrombosis. We had several important findings. First, we found that stent thrombosis was preceded by heavy physical exertion in 11.3% of patients. Most patients, however, were either asleep or performing light exercise. In a recent report describing 3 cases of stent thrombosis, the association with physical exertion was suggested. 22 Our results show that there is indeed circumstantial evidence that heavy physical exertion may play a role in stent thrombosis onset. Surely, it is unlikely that 11% of a population is engaged in heavy physical activity at a certain point in time. More research on this topic is warranted to confirm our findings and estimate the size of this risk factor. Previous studies using the case-crossover design have identified heavy physical exertion as a risk factor for acute myocardial infarction. 15, 17 Second, 4% of patients were hospitalized for surgery or invasive diagnostics. These conditions may have interfered with the antithrombotic medication regimen, thus causing stent thrombosis. Third, in 5.6% of patients medication noncompliance was explicitly documented. However, we found that a much larger proportion of patients did not use clopidogrel or ticlopidine for at least 30 days (2007 guideline) or 1 year (current guideline) after implantation of a baremetal stent or for at least 1 year after implantation of a drug-eluting stent, as is recommended by the American College of Cardiology/American Heart Association (ACC/AHA) guidelines. 33, 34 Fourth, about 4% of patients had an ongoing acute infection prior to stent thrombosis onset. Acute infections, particularly in the respiratory and urinary tract may well be triggers of stent thrombosis, since they have shown to increase the risk of other adverse cardiovascular events as well.
35-37 For instance, a large study in the United Kingdom demonstrated an increased risk of acute myocardial infarction and stroke in patients with a respiratory tract infection (including pneumonia) or an urinary tract infection. 36 Finally, we found Factor V Leiden in 2.4% of our patients. Although Factor V Leiden is a well known risk factor for venous thrombosis, we did not find higher prevalences of this condition in our patient sample compared to the general population (about 6%).
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In addition, multiple reports have suggested that Factor V Leiden is not associated with arterial thrombosis.
38,40
Limitations
It is important to note the limitations of our study. Given the number of theoretical mechanisms for circadian rhythms, but the modest number of patients reported, analysis of associations must be regarded as speculative.
Although we used prospectively collected data, this was a retrospective analysis. Because date and time of symptom onset were unavailable in some patients, our sample does not consist of consecutive Part 1 -Symptom onset patients. Also, data availability did not allow us to identify patients who had undergone a single index or stent thrombosis procedure at our center and the other procedure at another center. However, we believe lack of data was completely random and was unlikely to have biased our analysis. Furthermore, since stent thrombosis is a relatively rare complication, our sample size was limited. Therefore, this study may not have had enough statistical power to demonstrate circadian variation in late and very late stent thrombosis. The fact that we did not find a weekly pattern could also be due to limited power. Another limitation is that we did not study patients with sudden death. We recognize that stent thrombosis often leads to death, 25 but we chose not to include these patients since angiographic evidence of stent thrombosis could not be obtained. Another reason is that the well established circadian rhythm of sudden cardiac death 7, 9 would pose a potential source of bias in our analysis. However, exclusion of sudden deaths may account for the remarkable seasonal distribution we found. It may be possible that stent thrombosis is more severe during the winter, and thus causes more sudden deaths.
Finally, we did not include a control group in our analysis of potential triggers of stent thrombosis. Therefore, statements made regarding potential triggers could not be tested and this part of our analysis should be seen as merely explorative.
Conclusions
In conclusion, this study shows that 1) stent thrombosis follows a circadian rhythm with an early morning peak, 2) stent thrombosis follows a seasonal rhythm with a peak in the summer, and 3) potential triggers of stent thrombosis can be identified in a considerable number of patients, mainly exercise and conditions or behavior that interferes with an optimal medication regimen.
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